BCL6 and lymphoma: Intriguingly, the deregulated expression of BCL6 is associated with an increased malignancy of multiple cancer entities, such as lymphomas, breast cancer, and ovarian cancer, which correlates with increased invasion and metastatic rates [1,2,5,7,48].